Streetbeat News

Revenues

DIS

Traders are circulating a rumor about The Walt Disney Co. (DIS) based on an Unusual Whales Twitter post. The post suggests that Disney's upfront advertising revenue and volume commitments are in line with the previous year.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 7:58 pm

HIMS

Hims & Hers Health, Inc. (NYSE:HIMS) reported Q2 earnings, beating top and bottom lines, and raised its full year 2023 revenue guidance. The company reported quarterly losses of three cents per share, beating the analyst consensus estimate of losses of six cents. Quarterly sales were $207.91 million, beating the analyst consensus estimate of $204.62 million. Subscribers grew to 1.3 million, up 74% YoY. Full year 2023 revenue guidance was raised to between $830 million and $850 million. Credit Suisse analyst Jonathan Yong reiterated Hims & Hers Health with an Outperform and maintained the $14 price target.

Portfolio Pulse from Ryan Gustafson

August 08, 2023 | 7:28 pm

AAPL

According to Nikkei, Apple's App Store ecosystem has facilitated developers in generating billings and sales of $46 billion in Japan in 2022.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 6:15 pm

ABT

DXCM

PODD

TNDM

Shares of insulin and glucose monitoring companies are trading lower, possibly due to strong data from diabetes and weight loss drug makers Novo Nordisk and Lilly. This has led to increased sales growth for these companies, potentially impacting the market share of insulin and glucose monitoring companies.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:46 pm

CLBT

Cellebrite DI reported better-than-expected Q2 financial results and raised its FY23 revenue guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:22 pm

JELD

JELD-WEN Holding reported its Q2 financial results and updated its FY23 revenue guidance, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:17 pm

IRWD

Ironwood Pharmaceuticals reported its Q2 financial results and issued FY23 revenue guidance, which led to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:07 pm

PAYO

Payoneer Global reported better-than-expected Q2 financial results and issued FY23 revenue guidance above estimates, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:05 pm

WMK

Weis Markets reported a year-over-year increase in Q2 revenue results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:04 pm

SIBN

SI-BONe reported its Q2 financial results and issued FY23 revenue and worldwide revenue guidance, which led to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 4:59 pm